What is he best known for?
The fields of study he is best known for:
Cancer research, Sarcoma, Genetics, Pathology and DNA methylation are his primary areas of study.
The various areas that Timothy J. Triche examines in his Cancer research study include Germline mutation, MLH1, KRAS, microRNA and CDKN2A.
His Sarcoma study combines topics from a wide range of disciplines, such as RNA, Fusion gene and Gene expression profiling.
His Pathology research integrates issues from Ganglioneuroma, Neuroblastoma and Anatomy.
His DNA methylation research is multidisciplinary, incorporating elements of Preprocessor, Serous fluid, Exome, Bioconductor and Sequence analysis.
His study focuses on the intersection of MicroRNA sequencing and fields such as Exome sequencing with connections in the field of Cancer.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Comprehensive molecular characterization of human colon and rectal cancer (5012 citations)
- Integrated genomic analyses of ovarian carcinoma (4769 citations)
What are the main themes of his work throughout his whole career to date?
Timothy J. Triche mainly focuses on Cancer research, Internal medicine, Sarcoma, Pathology and Oncology.
His Cancer research study incorporates themes from Cancer, Metastasis, Cell culture, Neuroblastoma and DNA methylation.
As part of his inquiry into Genetics and Gene, Timothy J. Triche is doing DNA methylation research.
His work deals with themes such as Endocrinology and Cog, which intersect with Internal medicine.
His Sarcoma study incorporates themes from Chemotherapy and Gene expression profiling.
The study incorporates disciplines such as Prostatectomy, Prostate cancer, Clinical trial, Surgery and Cohort in addition to Oncology.
He most often published in these fields:
- Cancer research (34.22%)
- Internal medicine (23.18%)
- Sarcoma (20.09%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (34.22%)
- Computational biology (11.04%)
- Gene (13.91%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Computational biology, Gene, Oncology and Internal medicine.
His Cancer research research is multidisciplinary, relying on both Cancer, Metastasis, DNA methylation, Chromatin and Sarcoma.
In his study, which falls under the umbrella issue of Sarcoma, Ewing's sarcoma is strongly linked to Doxorubicin.
He has included themes like Genome and Whole genome sequencing in his Computational biology study.
His Gene research is under the purview of Genetics.
His Oncology study combines topics from a wide range of disciplines, such as Colorectal cancer, Clinical trial, Randomized controlled trial and Chemotherapy.
Between 2016 and 2021, his most popular works were:
- Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma (647 citations)
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. (200 citations)
- SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. (62 citations)
In his most recent research, the most cited papers focused on:
Timothy J. Triche mainly investigates Cancer research, Gene, Genome, Leukemia and Computational biology.
His biological study spans a wide range of topics, including Protein kinase B, DNA methylation, Transcriptome, KRAS and DNA sequencing.
His work is dedicated to discovering how KRAS, ARID1A are connected with microRNA and other disciplines.
His work carried out in the field of Gene brings together such families of science as Myeloid leukemia, Pathogenesis and Rhabdomyosarcoma.
The concepts of his Genome study are interwoven with issues in Osteosarcoma, Germline and Somatic cell.
Timothy J. Triche combines subjects such as Cancer, CRISPR, Psychological repression, Disease and Haplotype with his study of Computational biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
